Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21569088rdf:typepubmed:Citationlld:pubmed
pubmed-article:21569088lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:21569088lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:21569088lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:21569088lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:21569088lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:21569088lifeskim:mentionsumls-concept:C1427500lld:lifeskim
pubmed-article:21569088lifeskim:mentionsumls-concept:C0248419lld:lifeskim
pubmed-article:21569088lifeskim:mentionsumls-concept:C1826562lld:lifeskim
pubmed-article:21569088lifeskim:mentionsumls-concept:C0376249lld:lifeskim
pubmed-article:21569088lifeskim:mentionsumls-concept:C0009219lld:lifeskim
pubmed-article:21569088lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:21569088lifeskim:mentionsumls-concept:C1561491lld:lifeskim
pubmed-article:21569088pubmed:issue6lld:pubmed
pubmed-article:21569088pubmed:dateCreated2011-5-16lld:pubmed
pubmed-article:21569088pubmed:abstractTextGenome-wide association studies have identified >30 common variants associated with Type 2 diabetes (>5% minor allele frequency). These variants have small effects on individual risk and do not account for a large proportion of the heritable component of the disease. Monogenic forms of diabetes are caused by mutations that occur in <1:2000 individuals and follow strict patterns of inheritance. In contrast, the role of low frequency genetic variants (minor allele frequency 0.1-5%) in Type 2 diabetes is not known. The aim of this study was to assess the role of low frequency PDX1 (also called IPF1) variants in Type 2 diabetes.lld:pubmed
pubmed-article:21569088pubmed:languageenglld:pubmed
pubmed-article:21569088pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21569088pubmed:citationSubsetIMlld:pubmed
pubmed-article:21569088pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21569088pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21569088pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21569088pubmed:statusMEDLINElld:pubmed
pubmed-article:21569088pubmed:monthJunlld:pubmed
pubmed-article:21569088pubmed:issn1464-5491lld:pubmed
pubmed-article:21569088pubmed:authorpubmed-author:WalkerMMlld:pubmed
pubmed-article:21569088pubmed:authorpubmed-author:HitmanG AGAlld:pubmed
pubmed-article:21569088pubmed:authorpubmed-author:McCarthyM IMIlld:pubmed
pubmed-article:21569088pubmed:authorpubmed-author:EllardSSlld:pubmed
pubmed-article:21569088pubmed:authorpubmed-author:OlleM MMMlld:pubmed
pubmed-article:21569088pubmed:authorpubmed-author:KhamisAAlld:pubmed
pubmed-article:21569088pubmed:authorpubmed-author:FraylingT MTMlld:pubmed
pubmed-article:21569088pubmed:authorpubmed-author:WeedonM NMNlld:pubmed
pubmed-article:21569088pubmed:authorpubmed-author:EdghillE LELlld:pubmed
pubmed-article:21569088pubmed:authorpubmed-author:T...lld:pubmed
pubmed-article:21569088pubmed:copyrightInfo© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.lld:pubmed
pubmed-article:21569088pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21569088pubmed:volume28lld:pubmed
pubmed-article:21569088pubmed:ownerNLMlld:pubmed
pubmed-article:21569088pubmed:authorsCompleteYlld:pubmed
pubmed-article:21569088pubmed:pagination681-4lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:meshHeadingpubmed-meshheading:21569088...lld:pubmed
pubmed-article:21569088pubmed:year2011lld:pubmed
pubmed-article:21569088pubmed:articleTitleSequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes.lld:pubmed
pubmed-article:21569088pubmed:affiliationInstitute of Biomedical and Clinical Science Genetics of Complex Traits, Peninsula College of Medicine and Dentistry, University of Exeter, Barrack Road, Exeter, UK. emma.edghill@pms.ac.uklld:pubmed
pubmed-article:21569088pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21569088pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed